BridgeMD
New treatment option for Diabetes Mellitus, Type 2
Official title Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use
ClinicalTrials.gov ID: NCT07336329
What this study is testing
- What it's testing
- The goal of this clinical trial is to test whether wearing a continuous glucose monitor (CGM) part-time works as well as wearing it full-time in adults with type 2 diabetes who do not use insulin. The main questions it aims to answer are: Does wearing CGM part-time (2 weeks per month) control blood sugar as well as wearing it continuously?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 80
You may be able to join if
- Adults aged 19 to 80 years at the time of informed consent
- Adults with type 2 diabetes not using insulin
- Patients treated with GLP-1 agonist, oral hypoglycemic agents, and/or lifestyle modifications
- Patients who have maintained stable diabetes treatment for at least 3 months without changes
- HbA1c between 7.5% and 10.0%
You likely can't join if
- Type 1 diabetes mellitus
- Gestational diabetes mellitus
- History of pancreatectomy
- Continuous or intermittent insulin therapy for 7 days or more within 3 months
- Oral or IV steroid treatment within 1 month prior to informed consent
- Serious infection, surgery (scheduled or history), or severe trauma within 3 months prior to informed consent
See the full eligibility criteria
- Adults aged 19 to 80 years at the time of informed consent
- Adults with type 2 diabetes not using insulin
- Patients treated with GLP-1 agonist, oral hypoglycemic agents, and/or lifestyle modifications
- Patients who have maintained stable diabetes treatment for at least 3 months without changes
- HbA1c between 7.5% and 10.0%
- Willing to wear personal continuous glucose monitoring device (CGM)
- Willing to install and use CGM-linked app on personal smartphone with continuous access to WIFI or cellular data
- Able to read and write Korean as judged by investigator
- Willing to use medically acceptable contraception until end of study (sterile status, intrauterine device, or concurrent use of male/female barrier method with spermicide)
- Fully informed about the clinical trial and voluntarily consenting to participate
- Type 1 diabetes mellitus
- Gestational diabetes mellitus
- History of pancreatectomy
- Continuous or intermittent insulin therapy for 7 days or more within 3 months
- Oral or IV steroid treatment within 1 month prior to informed consent
- Serious infection, surgery (scheduled or history), or severe trauma within 3 months prior to informed consent
- History of malignancy within 1 year prior to informed consent (except thyroid cancer)
- On hemodialysis or peritoneal dialysis or eGFR \< 30 mL/min/1.73m2
- Unable to avoid the following concomitant medications, devices, or treatments during the study: CGM other than study device, X-ray/MRI/CT scans, radiofrequency thermal therapy, implantable devices such as pacemakers...
- Uncontrolled thyroid disease or clinically significant severe endocrine disorders (Cushing's syndrome, pheochromocytoma, etc.)
- Severe allergic reaction to skin adhesives (e.g., dyspnea, severe rash, edema)
- Whole blood donation within 60 days, apheresis within 30 days, or blood transfusion within 90 days prior to device application
- Judged by investigator as unable to handle continuous glucose monitoring device
- Pregnant or lactating women
- Planning pregnancy within 1 year
- Otherwise judged by investigator as inappropriate for participation in this clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.